Keyphrases
Reperfusion
100%
ST-elevation Myocardial Infarction (STEMI)
100%
Antiplatelet
100%
ST-segment Elevation MI
100%
Clinical Outcomes
66%
Ischemia-reperfusion Injury
66%
No-reflow
66%
Receptor Antagonist
33%
Pathophysiology
33%
Improved Outcomes
33%
Myocardial Fibrosis
33%
Adenosine Receptors
33%
Novel Pathways
33%
Aspirin
33%
Oral Administration
33%
Myocardial Ischemia-reperfusion Injury
33%
Patency
33%
Infarction
33%
Acute Myocardial Infarction
33%
Early Onset
33%
Myocardial Infarct Size
33%
In-hospital Mortality
33%
Myocardial Ischemia Injury
33%
Percutaneous Coronary Intervention
33%
Adjunctive Therapy
33%
Modern History
33%
Dynamic Nature
33%
Antiplatelet Agents
33%
Incremental Improvement
33%
Infarct
33%
Coronary Thrombolysis
33%
Inducible Ischemia
33%
Antiplatelet Therapy
33%
Time Rate
33%
Microvascular Damage
33%
Cardiomyocyte Death
33%
Early Reperfusion Therapy
33%
Antiplatelet Activity
33%
Adverse Remodeling
33%
P2Y12
33%
Door-to-balloon Time
33%
Epicardial Coronary Arteries
33%
Pharmacology, Toxicology and Pharmaceutical Science
ST Segment Elevation Myocardial Infarction
100%
Antiplatelet
100%
Reperfusion Injury
40%
Infarction
40%
No Reflow Phenomenon
40%
Injury
20%
Pathophysiology
20%
Pharmacotherapy
20%
Heart Muscle Ischemia
20%
Ischemia
20%
Acetylsalicylic Acid
20%
Heart Infarction
20%
Adenosine Receptor
20%
Acute Heart Infarction
20%
Hospital Mortality
20%
Heart Muscle Necrosis
20%
Antithrombocytic Agent
20%